猸愶笍猸愶笍猸愶笍猸愶笍猸愶笍 "A total no brainer"

猸愶笍猸愶笍猸愶笍猸愶笍猸愶笍 "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections

Official Title: Assessment of Postoperative Lymphopenia as Risk Factor for Postoperative Infections: EVALYMPH Study

Study ID: NCT02799251

Study Description

Brief Summary: Postoperative infections are one of the most common complications in thoracic and digestive cancer surgery. Former studies have demonstrated that inflammatory response is altered during peri-operative period causing lymphopenia. It has been suggested that lymphopenia may contribute to postoperative infection. To date, no one has proved it in a multivariate analysis. The aim of this study is to determine if lymphopenia is associated with postoperative infections in thoracic and digestive cancer surgery.

Detailed Description: Postoperative infections are one of the most common complications in thoracic and digestive cancer surgery. Former studies have demonstrated that inflammatory response is altered during peri-operative period causing lymphopenia. It has been suggested that lymphopenia may contribute to postoperative infection. To date, no one has proved it in a multivariate analysis. The aim of this study is to determine if lymphopenia is associated with postoperative infections in thoracic and digestive cancer surgery. It is a multicenter French cohort study. Lymphocytes counts are obtained from patients undergoing pulmonary or digestive cancer surgery before surgery (day-0) as well 1, 3, 5 and 8 days after surgery. Anesthetic and surgical procedures are collected as well as risk factors for postoperative infections recognized in the literature. Clinical and biological signs of infection are collected.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Chu Angers, Angers, , France

H么pital C么tes de Nacre CHU CAEN, Caen, , France

H么pital Estaing CHU CLERMONT-FERRAND, Clermont-Ferrand, , France

H么pital Beaujon CHU PARIS 1, Clichy, , France

H么pital Michallon CHU GRENOBLE, La Tronche, , France

H么pital Huriez CHRU LILLE, Lille, , France

H么pital Edouard Herriot CHU LYON, Lyon, , France

H么pital La croix Rousse CHU LYON, Lyon, , France

H么pital Lyon Sud CHU LYON, Lyon, , France

H么pital Nord CHU MARSEILLE, Marseille, , France

H么pital La Timone CHU MARSEILLE, Marseille, , France

H么pital H么tel-Dieu CHU NANTES, Nantes, , France

H么pital Car茅meau CHU NIMES, N卯mes, , France

H么pital Saint Louis-Lariboisi猫re CHU PARIS 5, Paris, , France

H么pital Saint-Antoine CHU PARIS 4, Paris, , France

H么pital La piti茅-Salpetri猫re CHU PARIS 3, Paris, , France

H么pital Bichat CHU PARIS 2, Paris, , France

H么pital Pontchaillou CHU RENNES, Rennes, , France

H么pital Central CHRU STRASBOURG, Strasbourg, , France

Centre de Lutte contre le Cancer, TOULOUSE, Toulouse, , France

Contact Details

Name: Serge Molliex, PhD

Affiliation: CHU de Saint-Etienne

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: